Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-26 | Amended | $6,809,726 | Unknown | Equity Only | SEC link | |
| 2024-07-23 | New | $743,385 | $743,385 | Equity Only | 06b | SEC link |
| 2023-03-15 | Amended | $9,889,371 | $4,452,074 | Equity Only | 06b | SEC link |
| 2021-06-22 | Amended | $5,437,297 | $0 | Equity Only | SEC link | |
| 2021-06-15 | New | $5,437,297 | Unknown | Equity Only | SEC link | |
| 2020-10-09 | New | $605,000 | $605,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Rudolf Bom | Director |
| Jason Burke | Executive |
| Lonnel Coats | Director |
| Theresa Firestone | Director |
| Jean Forcione | Director |
| Mark Groper | Director |
| Thomas Hecht | Director |
| Mark Hecht | Director |
| Katie Hewitt | Director |
| John Jussup | Executive |
| Anatole Klepatsky | Director, Executive |
| Anatolii Klepatsky | Director, Executive |
| Anatolii Klepatskyi | Director |
| Dmytro Martynenko | Director |
| Bradford Smith | Director |
| Praveen Tyle | Director, Executive |